サインイン 無料でサインアップします。

Navidea Biopharmaceuticals Incの収益

Navidea Biopharmaceuticals Incの収益は何ですか。

Navidea Biopharmaceuticals Incの収益は65.652k$です。

収益の定義は何ですか。



収入とは、企業が通常の事業活動から得た収入であり、通常は商品やサービスの顧客への売却による収入です。

Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.

In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.

NYSEMKTのセクタHealth Careにおける収益の企業と比べるNavidea Biopharmaceuticals Inc

Navidea Biopharmaceuticals Incは何をしますか。

navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de

Navidea Biopharmaceuticals Incと類似の収益